46% of NET patients are
diagnosed at an advanced stage
How Can I Help?
Latest News
2024 INCA/ENETS Symposium: Challenges and Strategies of Engaging Non-NEN Healthcare Professionals in Understanding NENs
The Annual INCA/ENETS Symposium on March 15th, 2024, showcased the joint strategy of patient advocates and ENETS experts in reaching out to educate primary care physicians and other medical specialists in neuroendocrine neoplasms detection and patient management. The...
LACNETS Educational Webinar About Tyrosine Kinase Inhibitors and NETs in March
Don’t miss the LACNETS educational webinar on March 29th, 2024, at 11:30 am PST. NET expert Dr. Jennifer Chan will present “TKIs: Tyrosine Kinase Inhibitors & Neuroendocrine Tumors”. Dr. Chan is the Vice President of the North American Neuroendocrine Tumor...
Barriers to Access High-Quality Care in NENs in EU: The Framework Is Here But We Need to Go Forward With Implementation
Within the 21st Annual ENETS Conference, a roundtable discussion on barriers to access high-quality care in NENs in the EU was held with some of the most prominent NEN medical experts, INCA leadership representative and the European Commission representative. Thus, a...